Login

Mr. Joseph Bugeja, Chairman and CEO of Transport Malta, discusses a metro system proposal in a public interview. 00:10:00

Share On Facebook Share On Twitter

Tavit Charuvajana is CEO/Exec Dir at Metro Systems Corp PCL

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Early-stage venture firm based in New York City with a global reach|Matthew Weinberg,Partner,Max Ventures
00:10:00
EDP CEO Miguel Stilwell d'Andrade on the Role of Utilities in the Low-Carbon Transition
00:10:00
Schroder Investment Manager Shares Top Stock Picks | Eamonn Rothwell - CEO of Irish Continental Group
00:00:00
Helius Medical Technologies; An Introduction to the Company Itself - Dane C. Andreeff President and Chief Executive Officer , Helius Medical Technologies Inc
00:10:00
Lexington Gold Upgrades Resource at Jones-Keystone Loflin, Assay Results from Argo Asset Show Promise | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Exploring Risk Management and Diversification: A Conversation with Dan Villalon, Global Co-Head of Portfolio Solutions at AQR Capital Management
00:10:00
Island Ties: Office of Healthcare Professionals Recruitment | Peter MacAskill, CEO, Government of Nova Scotia (TS)
00:10:00
CEO of Alpargatas, on Driving Innovation in a Legacy Brand | Roberto Funari, CEO , Alpargatas SA.
00:00:00
Evgen Pharma talks through clinical milestones and financial results from its 2022 full year report - Huw Jones, CEO, Evgen Pharma
00:10:00
Luke Martins on Turning Investing into the Ultimate Side Hustle | Luke Martins, CFP®, Financial Planning Coach, Old Mutual Wealth
00:10:00
Ville Kangasmuukko Reflects on Bubbleroom's Strategic Adjustments During the Pandemic | Ville Kangasmuukko, CEO, New Bubbleroom Sweden AB.
00:10:00
Moonfare's Co-Investment Strategy: Capitalizing on Private Equity Opportunities

© 2017 - Neuhu+